万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://academic.oup.com/jb
3、投稿网址：http://mc.manuscriptcentral.com/jb
4、官网邮箱：jb.editorialoffice@oup.com
5、期刊刊期：月刊，一年出版十二期。
2021年4月16日星期五
投稿须知【官网信息】
Instructions to Authors
The Journal of Biochemistry publishes the results of original research in the fields of Biochemistry, Molecular Biology, Cell, and Biotechnology, written in English, in the form of Regular Papers or Rapid Communications. The Journal also publishes short reviews (JB Review) and papers solicited by the Editorial Board.
When preparing your manuscript, please refer to ‘II. Review Process’ to ensure it is suitable for publication in the Journal. It is assumed by the Editorial Board members that any submitted manuscripts describe work that has not been published previously, and are not under consideration for publication elsewhere. Authors of manuscripts accepted for publication are required to grant the Japanese Biochemical Society an exclusive license to publish the work.
Submission should be made through the online submission system. For further information on online submission, please see: Instructions for Online Submission.
Journal policy requires that authors submit their manuscripts using the official email address of their affiliated institution. If this is not possible, please state the reason for using a non-official email address in your cover letter.
I. General Information
Article Types
Fields
II. Review Process
III. Form and Style of Manuscript
IV. Organization of Manuscript
1. Title Page(s)
2. Abstract
3. Introduction
4. Methods, Results, and Discussion
5. References
6. Figure Legends
7. Nucleotide Sequence
8. Symbol Nomenclature for Glycans
V. Preparation of Tables
VI. Preparation of Illustrations
VII. Colour Illustrations
VIII. Data
IX. Chemical and Mathematical Formulae
X. Author Responsibility
Authorship:
Conflict of Interest:
Funding:
XI. Scientific Misconduct
XII. Terminology and Abbreviations
XIII. Copyright
XIV. Open Access Option for Authors
XV. Publication Charges
Submission should be made through the online submission system. For further information on online submission, please see: Instructions for Online Submission.
I. General Information
Article Types
Regular Papers: Full-length research articles that contain original and novel findings that offer substantial contributions to biochemical sciences.
Rapid Communications: Similar to a regular paper but should present new findings of exceptional interest, novelty, and significance, which require rapid publication. Authors must state their reasons for submitting their paper under this category in their cover letter, including an explanation about the broad significance of the work and why it necessitates quick publication. Benefits for Rapid Communication authors include:
Quick review and publication times: Average of two weeks from submission to first decision and one week from acceptance to online publication
Three months free online access to your paper
Format-free submission (see III. Form and Style of Manuscript below)
Fields
On submission of a paper, authors are requested to select one of the following four fields and its topic, under which the submitted paper should be reviewed, and to indicate their selection on the title page of the manuscript.
Fields to be selected:
Biochemistry
Molecular Biology
Cell
Biotechnology
Topics to be selected:
Biochemistry
Biochemistry General; Protein Structure; Protein Interaction and Recognition; Biomolecular Structures; Nucleic Acid and Peptide Biochemistry; Glycobiology and Carbohydrate Biochemistry; Lipid Biochemistry; Enzymology; Enzyme Inhibitors; Biochemistry of Proteolysis; Metabolism and Bioenergetics; Reactive Oxygen and Nitrogen Species; Biochemistry in Cell Membranes; Biochemistry in Diseases and Aging; Neurochemistry; Immuno-chemistry; Physiological Chemistry; Biochemical Pharmacology; Analytical Biochemistry
Molecular Biology
Molecular Biology General; Genes and Other Genetic Materials; Replication and Recombination; Gene Expression; Protein Synthesis; DNA-Protein Interaction; RNA Processing; Genetic Engineering; Genetic Diseases; Molecular Genetics; Molecular Evolution; Bioinformatics
Cell
Cell General; Biomembranes, Organelles, and Protein Sorting; Muscles; Cytoskeletons, Cell Motility, and Cell Shape; Extracellular Matrices and Cell Adhesion Molecules; Cell Cycle; Receptors and Signal Transduction; Stress Proteins and Molecular Chaperones; Cell Death; Differentiation, Development, and Aging; Neurobiology; Tumor and Immunology
Biotechnology
Biotechnology General; Biomimetic Chemistry; Biomaterials; Bioactive Substances; Synthetic Peptides and Oligonucleotides; Gene and Protein Engineering; RNA Technology; Glycotechnology; Immunological Engineering; Cell and Tissue Engineering; Transgenic Technology; Gene Delivery Systems; Drug Delivery Systems; Biosensor and Bioelectronics; New Devices in Biotechnology; Environmental Technology
Language Editing
Particularly if English is not your first language, before submitting your manuscript you may wish to have it edited for language. This is not a mandatory step, but may help to ensure that the academic content of your paper is fully understood by journal editors and reviewers. Language editing does not guarantee that your manuscript will be accepted for publication. Information about such services. There are other specialist language editing companies that offer similar services and any of these can be used. Authors are liable for all costs associated with such services.
II. Review Process
Manuscripts will be sent to at least two referees for evaluation. The journal always attempts to minimize the potential for conflict of interest in the reviewing of manuscripts and, therefore, authors may request any individuals with possible conflict of interest not to be involved in the reviewing of their manuscript. Authors may provide the names and addresses of a few potential reviewers. The journal encourages authors to nominate Editor(s) and/or Associate Editor(s) that handles the manuscript. The Editors and Associate Editors will be guided, but not necessarily bound by these suggestions.
Contributors will receive an email from one of the Editors or Associate Editors stating whether their manuscript has been accepted. Revised manuscripts should be submitted through the online submission system. Correspondence concerning manuscripts should be sent directly to the relevant Editor. Revised papers will be considered as newly submitted papers if they are not resubmitted within 2 months with no justifiable reason. Handling of manuscripts is free of charge.Accepted manuscripts will be published online as 'Advance Articles' within 2 to 3 working days after acceptance. Authors should carefully follow instructions on Form and Style of Manuscript, as the pre-typeset manuscript will be published online. Authors with a justifiable reason for not wanting their papers to be published as “Advance Access”, should contact the Editorial Office upon submission.
Manuscripts will only be published in a formal issue after agreement by the author(s) to pay the costs of publication, including Color Charge. Alteration in galley proofs, other than the correction of printer’s errors, are not granted, except when the Editor admits addition of a brief note in proofs at the author’s expense. Galley proofs corrected by authors should be returned to the printer by a designated date, or they will not be published in a formal issue. Reprints can be purchased, in batches of 50 copies, at cost prices. They should be ordered using the Oxford Journals Author Services site.
Please check your manuscript against the following checkpoints before submitting it to the Journal of Biochemistry.
Is the subject suitable for publication in the Journal of Biochemistry?
Is it an original contribution?
Is it a complete and final paper?
Is it clearly presented?
Are the summary and title informative? Do they reflect the contents of the paper?
Are the appropriate key words given?
Does the introduction contain statements sufficient to explain the aim of the work?
Are the methods sound?
Are the results relevant and sufficient?
Are the illustrations and tables necessary and acceptable?
Are the interpretations and conclusions justified by the data?
Are the references adequate; are all of them necessary? Does the list of references contain all the information?
Please note that, as part of the review process, authors may occasionally be requested to provide the raw data underpinning the findings in their paper. Failure or unwillingness to do so may result in the paper being rejected. We thank you in advance for your cooperation.
III. Form and Style of Manuscript
Before submitting a manuscript, authors should ensure that they understand the journal scope and formatting requirements.
To increase the speed of peer review and publication, for Rapid Communications we now offer authors the option of submitting papers in any journal format and style. Manuscripts should, however, still contain the basic elements comprising an appropriate title, author list, abstract and references. Authors of accepted Rapid Communications submissions will be requested to reformat their paper to the journal style following peer review, if necessary.
Authors wishing to publish Regular Papers should also follow the specifications below:
There is no definitive length set for a Regular Paper.
Headings (Summary, Introduction with no heading, Experimental Procedures or Materials and Methods, Results, Discussion) should be indicated on the manuscript.
Authors wishing to publish Rapid Communications should also follow the specifications below:
In the cover letter, describe the urgency or necessity for rapid publication. (Please also indicate whether or not you would be willing for your paper to be handled as a Regular Paper if the editor decides that the criteria for being published as a Rapid Communication are not met.)
Headings (Summary, Introduction with no heading, Experimental Procedures or Materials and Methods, Results, Discussion) should be indicated on the manuscript.
Manuscripts should conform to the style and usage of the journal as demonstrated in current issues. They should be typed on A4 form (21×29.7 cm or 21.6×28 cm) with double-spacing throughout. Text should be double spaced, with font size between 10.5 to 11, and saved as a .DOC, or .RTF file. Separate pages should be used for the following: (1) title page(s), (2) summary, (3) text, (4) footnote(s) to the text, (5) references, (6) table(s), (7) legend(s) to figure(s), (8) figures or other subsidiary matters, (9) supplementary data (if any), (10) declaration of Funding and Conflict of Interest.
The manuscripts should be arranged in the order indicated above and all pages should be numbered in succession, except the figure(s), the title page being page 1. Indicate the appropriate location in the text of the tables, figures, and other subsidiary materials by marginal notes. Latin words should be italicized (for example: in vitro, i.e., etc., per se). Footnote(s) to the author’s name(s) and affiliation(s) should appear on the title page. All footnotes should be numbered in succession with superscript, Arabic numerals, starting from the title page footnote(s). Footnotes to tables should be identified with superscript lower case (a, b, etc.), and placed at the bottom of the table. Acknowledgements (if any) should appear after the main text, and before the References. It is advised that authors note any conflict of interest in this section.
IV. Organization of Manuscript
A desirable plan for the organization of regular or rapid papers is as follows: (a) TITLE PAGE(S), (b) SUMMARY, (c) INTRODUCTION with no heading, (d) EXPERIMENTAL PROCEDURES or MATERIALS AND METHODS, (e) RESULTS, (f) DISCUSSION, (g) REFERENCES. In some cases, presentation will be clearer and more effective if the author combines some of these sections.
1. Title Page(s)
Provide a title page(s), containing the following items.
The form of the paper (Regular Paper or Rapid Communication). The field and topic under which the paper is to be reviewed.
Title. The title should be informative and as short as possible without compromising on clarity. The title should not include chemical formulae or arbitrary abbreviations, but chemical symbols may be used to indicate the structures of isotopically labelled compounds. The numbering of parts in a series of papers is not permitted, but titles and subtitles may be used if necessary.
By-line. List the full names of all authors. A footnote reference(s) to an author(s), indicating a change of address, should be given on the title-page.
From-line. List the institution(s) in which the work was carried out, and the Zip Code, if available.
Running title. Provide a short running title of less than 60 characters. It should be as informative as possible.
The name, complete mailing address, telephone number, Fax number, and E-mail address of the person to whom correspondence should be sent. To expedite the review, much of the journal’s correspondence will be by E-mail.
Abbreviations. Non-standard abbreviations (see Section XII-6, 7, and 8) should be defined, even if they are known to those familiar with the field. List all non-standard abbreviations used in the paper, in alphabetical order, in a footnote on the title page.
2. Abstract
Every paper should have an abstract. The abstract should be written in less than 200 words and should briefly present the problem, suggest the scope of the work and the plan of experiments, mention significant data, and state major findings and conclusions. Avoid statements such as “The significance of these results is discussed” that do not help the reader. The abstract should be intelligible to the non-specialist as well as the specialist in your field, and hence should avoid specialized terms and abbreviations.
Authors are required to submit a graphical abstract or video abstract as part of the article, in addition to the text abstract. This is the case for all articles types except for Commentaries, for which graphical abstracts are optional. The graphical/video abstract should clearly summarize the focus and findings of the article, and will be published as part of the article online and in PDF. The graphical/video abstract should be submitted for peer review as a separate file, selecting the appropriate file-type designation in the journal’s online submission system. The file should be clearly named, e.g. graphical_abstract.tiff, video_abstract.mp4. For guidance on appropriate file format and resolution for graphics and videos, please see Preparing and Submitting your Manuscript. Note that graphical abstracts can be submitted either at initial submission stage, or when resubmitting the paper after revision.
Key words: Provide five key words identifying the nature of the subject matter, alphabetically in the last part of the summary.
3. Introduction
The text should begin with a short introduction with no heading. This should state the reasons for performing the work, with brief reference to previous work on the subject. Avoid giving an extensive review of the literature.
4. Methods, Results, and Discussion
The arrangement of the paper after the introduction is not fixed. The author may separate sections with italicized subheadings.
The Experimental Procedures or Materials and Methods should give sufficient detail to enable the reader to repeat your work exactly, if necessary. The necessity for conciseness should not lead to omission of important experimental details . Refer to previously published procedures employed by citation of both the original description and pertinent published modifications, and do not include extensive description unless they present substantially new modifications. Combination of the Results and Discussion in a single section sometimes gives a clearer and more compact presentation.
5. References
References cited in the text should be numbered in parentheses with italicized Arabic numerals in order of appearance. References to “unpublished experiments” and “personal communications” should appear parenthetically in the text following the name(s) of the source of information [(Yamada, T., personal communication), (Suzuki, M. and Yoshida, M., unpublished observations) etc .]. Be sure to verify the wording of any personal communication with the person who supplied the information and get their approval for the use of their names in connection with the quoted information. All references should be listed in numerical order, typed, and double-spaced on a separate sheet under the heading REFERENCES.
Please note the following examples.
For a journal article:
7. Sanger, F., Nicklen, S., and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74 , 5463–5467
For a chapter in an edited book:
12. Messing, J. (1983) New M13 vectors for cloning in Methods in Enzymology (Wu, R., Grossman, L., and Moldave, K., eds.) Vol. 101, pp. 20–51, Academic Press, New York
For a book by one or more authors:
15. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning. A Laboratory Manual pp. 1339–1341, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Text citations to references written by more than two authors should be styled for example as, Smith et al. In the reference list, however, the names of all authors (with initials) must be given. If an article has been accepted for publication by a journal but has not yet appeared in print, the reference should be styled as follows:
29. Tanahashi, H. and Ito, T. (1994) Molecular characterization of a novel factor recognizing the interleukin-6 responsive element. J. Biochem . (in press)
The use of “in preparation” and “submitted for publication” is not allowed in the reference list.
Citation of the references written in a language which is usually unreadable for general readers and those published in a journal (or book) which a general reader could not easily access, should be avoided.
6. Figure Legends
Figure legends should be prepared for each figure. There should be sufficient experimental detail in the legend to make the figure intelligible without reference to the text (unless the same material has been given with a previous figure, or in the Experimental Procedures section).
7. Nucleotide Sequence
New nucleotide data must be submitted and deposited in the DDBJ/EMBL/GenBank databases and an accession number obtained before the paper can be accepted for publication. Submission to any one of the three collaborating databanks is sufficient to ensure data entry in all. The accession number should be included in the manuscript as a footnote on the title page: E.g.“Note: Nucleotide sequence data reported are available in the DDBJ/EMBL/GenBank databases under the accession number(s)....”. If requested, the database will withhold release of data until publication. The most convenient method for submitting sequence data is via the World Wide Web:
DDBJ via SAKURA
EMBL via WEBIN
GenBankTM via Banklt
or stand-alone submission tool
Sequin
For special types of submissions ( e.g ., genomes, bulk submissions, etc .) additional submission protocols are available from the above sites.
Database Contact Information
DDBJ: Center for Information Biology and DNA Data Bank of Japan National Institute of Genetics, 1111 Yata, Mishima, Shizuoka 411-8540, JAPAN; telephone: 81 559 81 6853; fax: 81 559 81 6849; e-mail: ddbj@ddbj.nig.ac.jp
EMBL: EMBL Nucleotide Sequence Submissions, European Bioinfor-matics Institute, Wellcome Trust Genome Campus, Hinxton, Cam-bridge DB10 1SD U.K.; telephone: 44 1223 494499; fax: 44 1223 494472; e-mail: datasubs@ebi.ac.uk
GenBank: National Center for Biotechnology Information, National Library of Medicine, Bldg. 38A, Rm 8N-803, Bethesda, MD 20894, U.S.A.; telephone: 1 301 496 2475; fax: 1 301 480 9241; e-mail: info@ncbi.nlm.nih.gov
8. Symbol Nomenclature for Glycans
For glycan structures, we strongly recommend using the Symbol Nomenclature for Glycans (SNFG). Please include a citation to the legend of figures using these symbols such as, “Monosaccharide symbols follow the SNFG (Symbol Nomenclature for Glycans) system (PMID 26543186, Glycobiology 25: 1323–1324, 2015) details at NCBI".
V. Preparation of Tables
Tables should be drawn on separate pages and numbered consecutively in Roman numerals. For aid in designing tables in an acceptable style, refer to current issues of the journal.
Each table should have an explanatory title and sufficient experimental detail, usually in a paragraph immediately following the title, to be intelligible without reference to the text (unless the procedure is given in the Experimental Procedures section, or under another table or figure).
Indicate units of measurement clearly.
Footnotes to tables should be kept to a minimum and should be indicated by superscript lower cases at the bottom of the table.
Tables must be submitted as .DOC, .RTF, Excel or Power Point files.
VI. Preparation of Illustrations
Each figure (Scheme, Diagram) should be given on a separate file numbered with an Arabic numeral (Fig. 1, Fig. 2, etc.). Figures will be reduced to fit into the type area of the printed page (17.5 x 23.5 cm).
Indicate the magnification of photomicrographs in the legend or include a bar indicating the scale in the figure.
Flow diagrams and amino acid or nucleotide sequences should always be presented as direct photographic reproduction.
Figures must be submitted as .DOC, .EPS, .JPG, .PPT, .TIF, .PDF or .GIF.
VII. Colour Illustrations
The Journal of Biochemistry offers authors a Flexible Color Option. All figures submitted to the journal in colour will be published in colour online at no cost (unless the author specifically requests that their figures be in black and white online). Authors may choose to also publish their figures in colour in the print journal for £350 per figure: you will be asked to approve this cost after you have submitted your article for publication online. Please also note that a set of figures with the same tag is counted as one figure, i.e. Figure 1A, 1B, 1C are counted as one (Figure 1). Colour figures must have a resolution of at least 300 dots per inch at their final sizes. Please note: Figure captions must be suitably worded to apply to both the print and online versions of the article. Switching colour figures to black and white figures after acceptance may require Editorial approval.
VIII. Data
Availability of Data and Materials:
Where ethically feasible, Journal of Biochemistry strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. Information on general repositories for all data types, and a list of recommended repositories by subject area, is available on this webpage, and in the Nucleotide Sequence section above.
Please note that, as part of the review process, authors may occasionally be requested to provide the raw data underpinning the findings in their paper. Failure or unwillingness to do so may result in the paper being rejected. We thank you in advance for your cooperation.
Data Citation:
Journal of Biochemistry supports the Force 11 Data Citation Principles and requires that all publicly available datasets be fully referenced in the reference list with an accession number or unique identifier such as a digital object identifier (DOI). Data citations should include the minimum information recommended by DataCite:
[dataset]* Authors, Year, Title, Publisher (repository or archive name), Identifier
*The inclusion of the [dataset] tag at the beginning of the citation helps us to correctly identify and tag the citation. This tag will be removed from the citation published in the reference list.
Supplementary Data:
Supporting material that cannot be included, and which is not essential for inclusion in the full text of the manuscript, but would nevertheless benefit the reader, can be published online. Authors are encouraged to take advantage of the opportunity to submit Supplementary data whenever appropriate; for example, when the amount of material is too great to warrant inclusion in the main body of the paper, or when the material is in a format that cannot be represented in print (i.e. video clips or animated graphics). All material to be considered as Supplementary data must be submitted at the same time as the main manuscript for peer review. Please indicate clearly the material intended as Supplementary data upon submission. Also ensure that the Supplementary data is referred to in the manuscript at an appropriate point in the text. Supplementary data should be submitted in a separate file(s), in its final form. Please note that Supplementary data will not be edited, so ensure that it is clearly and succinctly presented, and that the style of terms conforms to the rest of the paper. Also ensure that the presentation will work on any internet browser.
Acceptable formats: A maximum of 10 files is acceptable to make up the supplementary data unit for the article. The maximum size per file should not exceed 1.5 MB. An HTML index page is usually created to link in the Supplementary data file(s). Please provide short (2–4 words) titles for each individual file—these will be used to create links to the files from the index page.
IX. Chemical and Mathematical Formulae
Refer in the text to simple chemical compounds by their formulae when these can be printed in simple horizontal lines of type. Do not use structural formulae in the running text.
Ionic charge should be shown as a superscript following the chemical symbol,
e.g . Fe 3? , SO 4 2- .
Prepare large structural formulae and long mathematical equations in a form suitable for direct photographic reproduction and include them as a Diagram at the end of the paper.
Isotopically Labelled Compounds —The symbol for an isotope is shown in square brackets directly before the name (word), as in [ 14 C]urea, [α- 14 C]leucine, DL-[methyl- 14 C]methionine. When more than one position in a substance is labelled with the same isotope and the positions are not indicated, the number of labelled atoms should be indicated as a right-hand subscript; as in [ 14 C 2 ]glycolic acid. The symbol U indicates uniform, e.g. [ U - 14 C]glucose (where the 14 C is uniformly distributed among all six positions). The isotopic prefix precedes that part of the name to which it refers, as in sodium [ 14 C]formate, thiamine [β- 32 P]diphosphate. Terms such as 131 I-labeled albumin should not be contracted to [ 131 I]albumin. When isotopes of more than one element are introduced, their symbols should be arranged in alphabetical order: e.g. L-[3- 14 C, 2,3- 2 H, 15 N]serine. The symbols 2 H and 3 H or D and T may be used for deuterium and tritium, respectively.
For simple molecules, the labelling is indicated by writing the chemical formulae with the prefix superscripts attached to the correct atomic symbols in the formulae: e.g. 14 CO 2 , H 2 18 O, 2 H 2 O. Square brackets should not be used for them, or when the isotopic symbol is attached to a word that is not a specific chemical name, abbreviation or symbol: e.g. 131 I-labeled, 14 C-sugar, 14 C-steroids, 32 PO 4 3- , but [ 32 P]-phosphate.
Spectrophotometric Data —Beer’s law may be stated as
A =–log T=εlc
Where A is the absorbance; T , the transmittance ( ?I / I 0 ); ε , the molar absorption coefficient; c , the concentration of the absorbing substances in moles per liter; and l , the length of the optical path in centimeters. Under these conditions); ε has the dimensions literámol -1 ácm -1 or more briefly M -1 ácm -1 (not cm -1 ámol -1 ). Do not use “O.D.” and “E.”
X. Author Responsibility
In scientific investigations involving human subjects, experiments should be performed in accordance with the ethical standards formulated in the Helsinki Declaration of 1964 (revised in 1989, cf . http://ohsr.od.nih.gov/). Similarly, animal experiments should follow the ethical standards formulated in the Helsinki Declaration, and measures taken to protect animals from pain or discomfort should be mentioned. All authors must read and sign the JB Authors’ Responsibility and Conflict of Interest Form. This form can be downloaded.
Authorship:
All persons designated as authors should qualify for authorship. The entitlement to authorship should be based on all of the following criteria: (1) substantial contributions to conceptions and design, execution or analysis and interpretation of data; (2) drafting the article or revising it for important intellectual content; (3) final approval of the version to be published. Acquisition of funding, collection of data, or general supervision of the research group alone, does not justify authorship. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements. The order of authorship should be a joint decision between the co-authors. Each author should have participated sufficiently in the work to take public responsibility for the whole or part of the content.
The submitting author must agree that the order of authorship has been confirmed by all authors when submitting a manuscript, and upload the signed Authors’ Responsibility and Conflict of Interest form along with the other manuscript files.
For more details on Authorship: International Committee of Medical Journal Editors' (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals
Author Self-Archiving Policy
Authors are allowed to deposit un-refereed author versions of their paper in community pre-print servers such as bioRixv.org, provided that entries are updated, if appropriate, to acknowledge that the article has been accepted/published by Journal of Biochemistry. For more details of our self-archiving policy, please visit our Author Self-Archiving policy page. If the paper has been deposited in a pre-print server, the authors are requested to mention this in their Cover Letter. Authors should contact the editorial office if they are in any doubt prior to submission. (More details are given below in Further Information on managing pre-prints after publication.)
Conflict of Interest:
The Journal of Biochemistry ’s policy requires that each author reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated, including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition.
When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?
As an integral part of the online submission process, corresponding authors are required to confirm whether they or their co-authors have any conflicts of interest to declare, and to provide details of these.
When submitting a manuscript, the corresponding author is required to submit a completed Authors’ Responsibility and Conflict of Interest form via the submission site along with the other manuscript files.
Japanese translation of the form is offered for author's reference. (NOTE: Submission of the form should be made with the original English version.)
If it is not possible to submit the completed form at the same time as submitting your manuscript, please email it as soon as possible as a PDF attachment to jb.editorialoffice@oup.com, making sure to include your manuscript number. Please note that papers whose COI forms are submitted separately may take longer to process than those whose forms are submitted online.
Funding:
Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgements' section.
Crossref Funding Data Registry . In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process. For further information on this process or to find out more about CHORUS, visit the CHORUS initiative.
The following rules should be followed:
The sentence should begin: ‘This work was supported by …’
The full official funding agency name should be given, i.e. ‘National Institutes of Health’, not ‘NIH’, see this RIN page.
Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers xxxx, yyyy]’.
Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency).
Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'.
An example is given here: ‘This work was supported by the National Institutes of Health [AA123456 to C.S., BB765432 to M.H.]; and the Alcohol & Education Research Council [hfygr667789].’
XI. Scientific Misconduct
Journal of Biochemistry is a member of the Committee on Publication Ethics (COPE) and investigates all potential cases of misconduct thoroughly on a case-by-case basis. If misconduct (e.g. data or figure manipulation, dual submission or plagiarism) is detected in a submitted paper, the editors reserve the right to reject it. If misconduct is found after a paper is published, it may be retracted by the Editor-in-Chief; a note of retraction will then be published and the online version will be labelled as ‘‘retracted’’. If you wish to reuse previously published material or previously unpublished material owned by another individual, you should seek permission and acknowledge it appropriately.
Manuscripts may be screened with iThenticate software, as part of the CrossCheck initiative to detect and prevent plagiarism. More information about CrossCheck. If the Editor-in-Chief is made aware of potential problems with papers published in another journal, he may contact that journal. If a case cannot be resolved by discussion with the author(s) and the Editor-in-Chief still has concerns, the Editor-in-Chief may report the case to the appropriate authorities (for example, COPE).
XII. Terminology and Abbreviations
Abbreviations with specific meanings may be used for convenience for complex chemical substances, particularly in equations, tables, or figures. Avoid using abbreviations in titles and summaries except the standard ones listed in Table II of Section XII-8.
Use abbreviations and symbols sparingly in the text. In chemical equations, which traditionally depend upon symbols, an abbreviation or symbol may be used for a term that appears in full in the neighbouring text. Trivial names are usually sufficiently short not to require abbreviations.
An abbreviated name or symbol in a column heading in a table, figure, or photograph must either be taken from the “accepted” list given in Section XII-8 or formulated in accordance with the principles of Section XII-6.
For spelling of chemical names consult current issues of the Journal. For chemical terms follow the usages and rules recommended by International Scientific Union, especially Nomenclature Committee of IUBMB (NC-IUBMB, IUBMB: International Union of Biochemistry and Molecular Biology) and IUPAC-IUBMB Joint Commission on Biochemical Nomenclature (JCBN, IUPAC: International Union of Pure and Applied Chemistry): see the recommendations in Biochemical Nomenclature and Related Documents (1978), available from The Biochemical Society, 7 Warwick Court, London WC1R 5DP, U.K. and in Biochemical Nomenclature and Related Documents. A Compendium , 2nd edn (LiŽbecq, C., ed.), Portland Press Ltd, London (1992). (see Eur. J. Biochem . 213 , 1–3 (1993)).
Refer also to this page.
Enzymes —Where one or more enzymes figure prominently in a manuscript, authors should use the recommended (trivial) name or systematic name given by Nomenclature Committee of IUBMB and IUPAC-IUBMB Commission on Biochemical Nomenclature: see
Enzyme Nomenclature, Recommendations (1992) , Academic Press, Inc.,
see also Eur. J. Biochem . 213 , 1–3 (1993).
—Supplement Eur. J. Biochem . 223 , 1–5 (1994).
—Supplement 2 Eur. J. Biochem . 232 , 1–6 (1995).
—Supplement 3 Eur. J. Biochem . 237 , 1–5 (1996).
—Supplement 4 Eur. J. Biochem . 250 , 1–6 (1997).
When an enzyme is the main subject of a paper, its source, trivial name, systematic name (or the reaction that it catalyzes) and code number (preceded by “EC”) should be included.
Non-Standard Abbreviations —Use of abbreviations other than the standard ones listed in XII-7 and XII-8 should be kept to a minimum. Such abbreviations should be introduced only when absolutely necessary, as in tables, figures, and other illustrations where space is particularly limited. Abbreviations are usually not needed in the text of a paper where repeated use of long names can be avoided by judicious use of pronouns, or by paraphrasing with words such as “the substrate,” “the inhibitor,” “the methyl derivative,” etc . All non-standard abbreviations used in the text should be defined in alphabetical order in a single footnote on the title page.
Abbreviations of Units of Measurement and Physical and Chemical Quantities —These abbreviations listed in Table I may be used without definition.
Abbreviations of Units of Measurement and Physical and Chemical Quantities
Accepted Abbreviations and Symbols —Authors may use, without definition, the abbreviations given in Table II and the symbols and abbreviations for amino acid or nucleotide residues in polymers or sequences. Define other abbreviations in a single footnote on the title page.
Names of Animals, Plants, and Microorganisms —The scientific names are Latin binomials and should be given in full in the title and summary and on first mention in the text ( e.g. Escherichia coli ). Subsequently, the generic name may be contracted (usually to the first letter), e.g., E. coli . The strain of laboratory animals and if possible the source should be stated.
The cytochromes should be designated by a small italicized letter, e.g. cytochrome a , b 2 , c 1 , etc .
Accepted Abbreviations and Symbols
XIII. Copyright
The author retains the copyright for each article. All authors must sign the License to Publish form to grant the Journal of Biochemistry a license to publish the accepted article, when the manuscript is accepted. Requests for any reproduction or translation of this journal should be made to Oxford University Press via the contact information below:
Contact details for Permissions: Rights and New Business Development, Oxford Journals, Oxford University Press,
Great Clarendon Street, Oxford OX2 6DP Tel: +44 (0) 1865 353561;
Email: Journals.Permissions@oup.com
Rights and Permissions page
A statement of intended use should also be included as well as explicit specifications of the material to be reproduced.
Authors are advised to consult “Notes to Contributors” which appears in every issue of the Journal in which any revisions of “Instructions to Authors” will be announced.
Further Information:
Full details of OUP’s publication rights policies, including author rights.
Use of PRE-PRINTS and POST-PRINTS (as defined in the Notes below)
On publication of your article in the Journal you are not required to remove any previously posted PRE-PRINT versions from your own personal website or that of your employer or free public servers of pre-prints and/or articles in your subject area, provided (1) you include a link (url) to the published version of the article on the Journal’s website; and (2) the Journal is attributed as the original place of publication with the correct citation details given.
You may post the POST-PRINT version of the article (but not the published version itself) onto your own website, your institution’s website and in institutional or subject-based repositories, such as PubMed Central or the Oxford Eprints service, PROVIDED THAT it is not made publicly available until 12 MONTHS after the online date of publication, and that: (1) you include a link (url) to the published version of the article on the Journal’s website; (2) the Journal is attributed as the original place of publication with the correct citation details given.
If the article is published under the open access model, provided you have paid the appropriate open access charge, you may deposit the POST-PRINT and/or the finally published version of the article into an institutional or centrally organized repository, immediately upon publication PROVIDED THAT (1) you include a link (url) to the published version of the article on the journal’s website and (2) the Journal is attributed as the original place of publication with the correct citation details given.
Notes:
Pre-Print: an unreferred manuscript version of the article, as submitted for review.
Post-Print: a final draft of an author manuscript that has been accepted with suggestions but before it has undergone copyediting and proof correction.
Free link to published article
On publication of your article, you will receive a URL, giving you access to the published article on the Journal website, and information on the use of this link.
Educational use
You may use the Article within your employer’s institution or company, for educational or research purposes only, including use in course-packs, as long as: (1) you do not use it for commercial purposes or re-distribution outside of the institution/company and (2) you acknowledge the Journal as the original place of publication with the correct citation details given.
XIV. Open Access Option for Authors
The Journal of Biochemistry offers the option of publishing under either a standard licence or an open access licence. Please note that some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please do clarify any such requirements with your funder or institution.
Should you wish to publish your article open access, you should select your choice of open access licence in our online system after your article has been accepted for publication. You will need to pay an open access charge to publish under an open access licence.
Details of the open access licences and open access charges.
OUP has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating.
Please note that you may be eligible for a discount to the open access charge based on society membership. Authors may be asked to prove eligibility for the member discount.
XV. Publication Charges
Author charges consist of Colour Charge, but there are no Page Charge.
Colour Charge: Please refer to VII. COLOUR ILLUSTRATIONS.
